Hrt Financial LP Celularity Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.42 - $0.81 $58,836 - $113,471	140,088 New	140,088 $74,000
Q2 2022 Aug 12, 2022	SELL	$2.81 - $12.91 $467,409 - $2.15 Million	-166,338 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $239,927 - $616,505	62,973 Added 60.92%	166,338 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$4.64 - $7.46 $192,430 - $309,381	-41,472 Reduced 28.63%	103,365 $529,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $12.15 $876,263 - $1.76 Million	144,837 New	144,837 $1.03 Million

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.